GoodRx
GDRX
4,32 €
Share price
0.20%
Change (1 day)
-46.86%
Change (1 year)
Categories
GoodRx (GDRX) - Cash on Hand
Cash on Hand as of March 2025 : €0.25 Billion
According to GoodRx's latest financial reports the company has €0.25 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
GoodRx - Cash on Hand chart (from 2019 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | €0.43 B | -29.16% |
| 2023-12-31 | €0.60 B | -13.84% |
| 2022-12-31 | €0.70 B | -15.06% |
| 2021-12-31 | €0.83 B | 5.52% |
| 2020-12-31 | €0.78 B | 3286.75% |
| 2019-12-31 | €23.25 M | -23.11% |
| 2018-12-31 | €30.24 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Perion Network PERI | €0.30 B | 19.10% | 🇮🇱 Israel |